Removing EPO signalling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Hepatocellular carcinoma (HCC) is a primary liver cancer that often occurs in patients with non-viral chronic liver disease ...

With liver ailments on the rise, and obesity a key driver, understanding the treatment options available is critical.

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...

The Risk Estimation of Tumor REcurrence After Transplant score accurately predicted hepatocellular carcinoma recurrence after liver transplantation.

A NEW study has suggested that deep-learning (DL) radiopathomics models can help predict the presence of vessels encapsulating tumour clusters (VETC) in hepatocellular carcinoma (HCC ... which ...

As the majority of patients with hepatocellular carcinoma (HCC) exhibits primary or acquired ... Tumour biopsies from 26 patients were analysed by scRNA-seq, standard histopathology assessment or ...